Investing.com - NRX Pharmaceuticals (NASDAQ: NRXP) reported third quarter EPS of $-0.070, $0.04 better than the analyst estimate of $-0.110. Revenue for the quarter came in at $0 versus the consensus estimate of $0.
NRX Pharmaceuticals's stock price closed at $0.340. It is up 1.490% in the last 3 months and down -63.930% in the last 12 months.
NRX Pharmaceuticals saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See NRX Pharmaceuticals's stock price’s past reactions to earnings here.
According to InvestingPro, NRX Pharmaceuticals's Financial Health score is "fair performance".
Check out NRX Pharmaceuticals's recent earnings performance, and NRX Pharmaceuticals's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar